# Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

> **NCT01436032** · PHASE3 · TERMINATED · sponsor: **Alkermes, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Laparoscopic Surgery

## Interventions

- **DRUG:** N1539
- **DRUG:** N1539
- **DRUG:** N1539
- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01436032
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436032, "Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01436032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*